InSitu Biologics welcomed into UAE in5 Incubator

By The Science Advisory Board staff writers

March 18, 2022 -- Oakdale, MI-based InSitu Biologics has been welcomed into in5, one of the United Arab Emirates' leading incubators, which specializes in supporting tech, media, and design startups.

The company said that the partnership will allow InSitu Biologics to advance its ability to conduct investigational and clinical studies internationally, secure funding, and build important partnerships in the region.

InSitu will also be presenting as in5's first health partner company in the upcoming Advance Health event "Future of Biotech R&D in UAE." The company participated in the Arab Health 2022 conference in January.

More information about in5 can be found on its site.

Copyright © 2022

Microscopy and Microanalysis Meeting
July 31 - August 4
Portland, Oregon United States
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter